A $4 million investment from the Government of Canada is set to propel McMaster University to increase its capabilities in healthcare innovation by establishing the Centre for Collaborative Chemistry, commonly known as C3. This was announced on November 28 by the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). The funding is part of the government’s larger strategy to drive innovation and collaboration within Canada’s life sciences sector.
C3 will become a part of McMaster University’s Global Nexus initiative-an accelerator for health innovation bringing academia, industry, and government together. Minister Tassi was visiting the university to make it clear how this new facility will help in implementing advanced scientific equipment that speeds up drug discovery in Canada. The Centre will house a state-of-the-art research hub, facilitating and nurturing the development for eventual commercialization of pharmaceuticals to create a collaborative framework in which scientists, entrepreneurs, and businesses can get together.
This investment shall improve the research capabilities in the Centre while offering opportunities for highly qualified personnel within the region to get focused training, mentorship, as well as collaboration opportunities at small and medium-sized enterprise levels. It is further expected to strengthen Canada’s competitive advantage in the international life sciences market while improving its health outcomes for Canadians through even faster and more efficient drug development, as well as health solutions.
Funding complements efforts by the Government of Canada to support innovation in the life sciences sector.
In supporting Canadian institutions and businesses in the development of innovative capacities, the government continues to boost the country’s ability to deliver transformative solutions for health care, including meeting its own needs, but also for international market competitiveness.
This investment will contribute to the development of a stronger health care system while nurturing an environment that encourages ongoing innovation and collaboration for the Government of Canada. The Centre for Collaborative Chemistry is well positioned to drive forward the pharmaceutical research landscape in Canada, as well as stimulate regional economic growth.
